Nasr Deena M, Rabinstein Alejandro A
Department of Neurology, Mayo Clinic, Rochester, MN, USA.
J Clin Neurol. 2015 Oct;11(4):383-9. doi: 10.3988/jcn.2015.11.4.383. Epub 2015 Aug 21.
The rate and outcomes of neurologic complications of patients receiving extracorporeal membrane oxygenation (ECMO) are poorly understood. The purpose of this study was to identify these parameters in ECMO patients.
All patients receiving ECMO were selected from the Nationwide Inpatient Sample between 2001-2011. The rate and outcomes of neurologic complications [acute ischemic stroke, intracranial hemorrhage (ICH), and seizures] among these patients was determined. Discharge status, mortality, length of stay, and hospitalization costs were compared between patients with and without neurologic complications using chi-squared tests for categorical variables and Student's t-test for continuous variables.
In total, 23,951 patients were included in this study, of which 2,604 (10.9%) suffered neurologic complications of seizure (4.1%), stroke (4.1%), or ICH (3.6%). When compared to patients without neurologic complications, acute ischemic stroke patients had significantly higher rates of discharge to a long-term facility (12.2% vs. 6.8%, p<0.0001) and a significantly longer mean length of stay (41.6 days vs. 31.9 days, p<0.0001). ICH patients had significantly higher rates of discharge to a long-term facility (9.5% vs. 6.8%, p=0.007), significantly higher mortality rates (59.7% vs. 50.0%, p<0.0001), and a significantly longer mean length of stay (41.8 days vs. 31.9 days) compared to patients without neurologic complications. These outcomes did not differ significantly between seizure patients and patients without neurologic complications.
Given the increasing utilization of ECMO and the high costs and poor outcomes associated with neurologic complications, more research is needed to help determine the best way to prevent these sequelae in this patient population.
接受体外膜肺氧合(ECMO)治疗的患者发生神经并发症的发生率及预后情况尚不清楚。本研究旨在明确ECMO患者的这些参数。
选取2001年至2011年间全国住院患者样本中所有接受ECMO治疗的患者。确定这些患者中神经并发症(急性缺血性卒中、颅内出血[ICH]和癫痫发作)的发生率及预后情况。对于分类变量,采用卡方检验比较有神经并发症和无神经并发症患者的出院状态、死亡率、住院时间和住院费用;对于连续变量,采用学生t检验进行比较。
本研究共纳入23951例患者,其中2604例(10.9%)发生了癫痫发作(4.1%)、卒中(4.1%)或ICH(3.6%)等神经并发症。与无神经并发症的患者相比,急性缺血性卒中患者转至长期护理机构的比例显著更高(分别为12.2%和6.8%,p<0.0001),平均住院时间显著更长(分别为41.6天和31.9天,p<0.0001)。与无神经并发症的患者相比,ICH患者转至长期护理机构的比例显著更高(分别为9.5%和6.8%,p=0.007),死亡率显著更高(分别为59.7%和50.0%,p<0.0001),平均住院时间显著更长(分别为41.8天和31.9天)。癫痫发作患者与无神经并发症患者之间的这些预后情况差异无统计学意义。
鉴于ECMO的使用日益增多,且神经并发症相关的高成本和不良预后,需要更多研究来帮助确定预防该患者群体这些后遗症的最佳方法。